11 employees
Elastrin Therapeutics is a biotech company developing novel therapies to reverse cardiovascular disease.
2017
$10M
from 3 investors over 3 rounds
Elastrin Therapeutics Inc. raised $10M on April 7, 2022
Investors: KIZOO and SCRA Technology Ventures
Elastrin Therapeutics Inc. raised $2.5M on March 4, 2021
Investors: KIZOO